Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the key differences and similarities between Imfinzi (durvalumab) and Keytruda (pembrolizumab), two powerful immunotherapy drugs used in cancer treatment. Learn about their uses, administration, potential side effects, and how to choose the right option with your doctor.
Navigating cancer treatment can feel overwhelming, especially when faced with multiple medication options. Two such treatments, Imfinzi (durvalumab) and Keytruda (pembrolizumab), are powerful immunotherapy drugs that help your body fight cancer. While both are designed to boost your immune system's ability to attack cancer cells, they have differences in their approved uses, administration, and potential side effects. Understanding these distinctions is vital for you and your doctor to make the most informed decision about your care.
Imfinzi and Keytruda belong to a class of drugs called immunotherapy. Unlike traditional chemotherapy that directly targets fast-growing cells (including some healthy ones), immunotherapy works by harnessing your own immune system. These drugs are specifically designed to block a protein that cancer cells use to hide from your immune system. By blocking this protein, they essentially 'unmask' the cancer cells, allowing your immune cells to find and destroy them more effectively.
Both medications are prescription-only and are administered as intravenous (IV) infusions. This means they are slowly given into your vein through an IV line, typically at a doctor's office or a hospital. They are biologic drugs, meaning they are made from living organisms, and currently, there are no generic or biosimilar versions available for either Imfinzi or Keytruda.
The primary similarity between Imfinzi and Keytruda lies in their mechanism of action and their overall goal: to activate your immune system against cancer. They are both effective in treating certain types of cancer, particularly:
Additionally, Keytruda is approved for certain forms of endometrial cancer and solid tumors with specific genetic markers. Your doctor will determine if your cancer type and characteristics make you a candidate for either of these treatments.
While they share a common purpose, there are important differences:
Imfinzi (durvalumab) is approved for specific types of lung cancer, biliary tract cancer, liver cancer, and certain types of endometrial cancer. Its use is generally limited to adults.
Keytruda (pembrolizumab) has a broader range of approved uses. Besides many of the same cancers Imfinzi treats, Keytruda is also used for:
Importantly, Keytruda can be used in children for certain types of cancer, while Imfinzi is not approved for pediatric use.
Both drugs are given as IV infusions. However, the frequency and duration can differ:
Your doctor will tailor the schedule based on your specific cancer and treatment plan, which might also include chemotherapy.
As with any powerful medication, Imfinzi and Keytruda can cause side effects. These can range from mild to severe. It's essential to discuss potential side effects with your doctor. Some common side effects reported for both drugs include:
More serious side effects can occur, often related to the immune system becoming overactive and attacking healthy tissues. These can include pneumonitis (lung inflammation), hepatitis (liver inflammation), colitis (colon inflammation), endocrinopathies (hormone gland issues), and severe skin reactions. If you experience any signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat, difficulty breathing, or a severe skin rash, seek immediate medical attention by calling 911 or your local emergency number.
The decision between Imfinzi and Keytruda, or any other cancer treatment, is highly personal. It depends on several factors:
A Real-Life Scenario: Imagine Mrs. Sharma, a 65-year-old woman recently diagnosed with advanced lung cancer. Her oncologist explains that both Imfinzi and Keytruda are options, but Keytruda has broader approvals for her specific subtype and is also approved for a combination therapy that might offer a better chance of response. They discuss the infusion schedules, potential side effects, and her overall health. Mrs. Sharma, after careful consideration and consultation, opts for Keytruda, understanding it aligns better with her treatment goals.
Your oncologist is your primary guide. Be sure to ask questions like:
It is crucial to stay in close contact with your healthcare team throughout your treatment. Report any new or worsening symptoms immediately. This includes:
Prompt reporting allows your doctor to manage side effects effectively and adjust your treatment if necessary.
Yes, both Imfinzi and Keytruda can be used in combination with chemotherapy for certain types of cancer. Your doctor will determine if this combination approach is appropriate for your treatment plan.
Immunotherapy can have long-term effects, as the immune system can remain altered. Some side effects, like immune-related toxicities, can occur months or even years after treatment has ended. Regular follow-up care is essential to monitor for any delayed effects.
The duration of treatment varies greatly depending on the type and stage of cancer, how your body responds to the medication, and whether side effects occur. Your doctor will discuss the expected treatment timeline with you.
If you have an autoimmune disease, your doctor will carefully consider the risks and benefits. Immunotherapy works by activating the immune system, which could potentially worsen an existing autoimmune condition. This is a critical point to discuss with your specialist.
Confused about whether CBD can get you high? Understand the difference between CBD and THC, their effects on your body, and what to look for in safe, non-intoxicating CBD products.
April 1, 2026
Learn about anticoagulants and antiplatelet drugs, often called blood thinners. Understand how they prevent blood clots, when they're prescribed, their side effects, and essential safety tips for Indian readers.
April 1, 2026
Confused about Plan B and abortion pills? Understand the key differences, how they work, and their effectiveness for informed reproductive health decisions.
April 1, 2026